Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on June 10, 2025
Access Medical Labs, a Subsidiary of Empresas Aries, Completes Historic Lab Expansion with Roche Diagnostics Systems
GlobeNewswire
·
June 10, 2025
JUPITER, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- In a milestone rarely achieved in the clinical laboratory industry, Access Medical Labs — the largest private diagnostic lab in Florida — has completed a full transition from Siemens to Roche Diagnostics …
Safe Group announces FDA 510(k) clearance for SpineUp's Frida solution
GlobeNewswire
·
June 10, 2025
Safe Group announces FDA 510(k) clearance for SpineUp's Frida solution Fleurieux-sur-l’Arbresle - France - June 5, 2025 at 6 p.m. Safe Group, a leading player in the field of medical devices for spine surgery, is pleased to announce that Frida, the …
AMPS Launches TruPrice: Smarter, More Accurate Claim Pricing Technology
GlobeNewswire
·
June 10, 2025
PHOENIX, June 10, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (AMPS), a leading healthcare cost savings technology company, has officially launched TruPrice, a proprietary repricing software that redefines how healthcare organizations …
BESLER renews HFMA Peer Review designation
GlobeNewswire
·
June 10, 2025
CHICAGO, June 10, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, BESLER has once again achieved the Peer Reviewed by HFMA® designation for its Revenue Integrity Solutions …
Announcing the 2025 Philadelphia Titan 100 Recipients
GlobeNewswire
·
June 10, 2025
BERWYN, Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Titan CEO is pleased to announce that Bill Oldham, chairman and president, AscellaHealth, has been inducted as one of only 10 honorees into the 2025 Philadelphia Titan 100 Hall of Fame, while John Campolongo, …
International Myeloma Foundation (IMF) to Honor 2025 Kyle and Durie Achievement Awardees, Dr. Sagar Lonial and Dr. Sonja Zweegman
GlobeNewswire
·
June 10, 2025
MILAN, June 10, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the International Myeloma Working Group (IMWG) are proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie Outstanding …
Shades for Migraine Drives Awareness and Action to Break Migraine Stigma
GlobeNewswire
·
June 10, 2025
Providence, RI, June 10, 2025 (GLOBE NEWSWIRE) -- The nonprofit Association of Migraine Disorders is changing the conversation around migraine disease through its global Shades for Migraine awareness campaign. Combining visibility with action, Shades for …
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution
GlobeNewswire
·
June 10, 2025
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new collaboration with Amazon’s Health Benefits Connector to expand access to comprehensive women’s …
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
GlobeNewswire
·
June 10, 2025
BERKELEY, Calif. and MAINZ, Germany, June 10, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announces the commencement of …
Iovance Biotherapeutics to Present at Upcoming Conference
GlobeNewswire
·
June 10, 2025
SAN CARLOS, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
GlobeNewswire
·
June 10, 2025
MALVERN. Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
Rose Hill Life Sciences to Spotlight Leading Research Partners at Psychedelic Science 2025
GlobeNewswire
·
June 10, 2025
Dr. Gül Dölen, MD, PhD, to share groundbreaking research on how psychedelic compounds can reopen “critical periods” of brain plasticity. Rotem Petranker, PhD, to discuss the latest findings from controlled clinical trials investigating the effects of …
Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology
GlobeNewswire
·
June 10, 2025
Ness-Ziona, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a poster at the European Alliance of …
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
GlobeNewswire
·
June 10, 2025
SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present …
Vivani Medical to Present at the 2025 BIO International Convention
GlobeNewswire
·
June 10, 2025
ALAMEDA, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, …
Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
GlobeNewswire
·
June 10, 2025
ISELIN, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish Medicines …
Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt
GlobeNewswire
·
June 10, 2025
Ashvattha will present Phase 2 data on migaldendranib, a subcutaneous therapy for DME and wet AMD, which could offer a more patient-friendly alternative to current injection-based treatments Company is exploring new technology to normalize VEGF expression, …
MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions
GlobeNewswire
·
June 10, 2025
CARMEL, Ind., June 10, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
GlobeNewswire
·
June 10, 2025
BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic …
DeepView® System highlighted at the annual British Burn Association conference
GlobeNewswire
·
June 10, 2025
DALLAS, June 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today …